vs
Side-by-side financial comparison of Mobileye Global Inc. (MBLY) and Natural Grocers by Vitamin Cottage, Inc. (NGVC). Click either name above to swap in a different company.
Mobileye Global Inc. is the larger business by last-quarter revenue ($558.0M vs $335.6M, roughly 1.7× Natural Grocers by Vitamin Cottage, Inc.). On growth, Mobileye Global Inc. posted the faster year-over-year revenue change (27.4% vs 1.6%). Over the past eight quarters, Mobileye Global Inc.'s revenue compounded faster (12.7% CAGR vs 4.4%).
Mobileye Global Inc. is a United States-domiciled, Israel-headquartered autonomous driving company. It is developing self-driving technologies and advanced driver-assistance systems (ADAS) including cameras, computer chips, and software. Mobileye was acquired by Intel in 2017 and went public again in 2022.
Natural Grocers by Vitamin Cottage, Inc. is a U.S.-based specialty retail chain that offers certified organic groceries, dietary supplements, natural personal care items, and eco-friendly household products. It serves health-conscious consumers across multiple U.S. states, following strict quality standards that exclude artificial preservatives, colors, flavors and harmful additives.
MBLY vs NGVC — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $558.0M | $335.6M |
| Net Profit | — | $11.3M |
| Gross Margin | 49.3% | 29.5% |
| Operating Margin | -647.5% | 4.4% |
| Net Margin | — | 3.4% |
| Revenue YoY | 27.4% | 1.6% |
| Net Profit YoY | — | 14.0% |
| EPS (diluted) | — | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $558.0M | — | ||
| Q4 25 | $446.0M | $335.6M | ||
| Q3 25 | $504.0M | $336.1M | ||
| Q2 25 | $506.0M | $328.7M | ||
| Q1 25 | $438.0M | $335.8M | ||
| Q4 24 | $490.0M | $330.2M | ||
| Q3 24 | $486.0M | $322.7M | ||
| Q2 24 | $439.0M | $309.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-127.0M | $11.3M | ||
| Q3 25 | $-96.0M | $11.8M | ||
| Q2 25 | $-67.0M | $11.6M | ||
| Q1 25 | $-102.0M | $13.1M | ||
| Q4 24 | $-71.0M | $9.9M | ||
| Q3 24 | $-2.7B | $9.0M | ||
| Q2 24 | $-86.0M | $9.2M |
| Q1 26 | 49.3% | — | ||
| Q4 25 | 45.3% | 29.5% | ||
| Q3 25 | 48.2% | 29.5% | ||
| Q2 25 | 49.8% | 29.9% | ||
| Q1 25 | 47.3% | 30.3% | ||
| Q4 24 | 49.2% | 29.9% | ||
| Q3 24 | 48.8% | 29.6% | ||
| Q2 24 | 47.6% | 29.2% |
| Q1 26 | -647.5% | — | ||
| Q4 25 | -31.4% | 4.4% | ||
| Q3 25 | -21.6% | 4.6% | ||
| Q2 25 | -14.6% | 4.7% | ||
| Q1 25 | -26.7% | 5.2% | ||
| Q4 24 | -17.6% | 4.0% | ||
| Q3 24 | -577.6% | 3.7% | ||
| Q2 24 | -21.4% | 4.2% |
| Q1 26 | — | — | ||
| Q4 25 | -28.5% | 3.4% | ||
| Q3 25 | -19.0% | 3.5% | ||
| Q2 25 | -13.2% | 3.5% | ||
| Q1 25 | -23.3% | 3.9% | ||
| Q4 24 | -14.5% | 3.0% | ||
| Q3 24 | -558.6% | 2.8% | ||
| Q2 24 | -19.6% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.15 | $0.49 | ||
| Q3 25 | $-0.12 | $0.51 | ||
| Q2 25 | $-0.08 | $0.50 | ||
| Q1 25 | $-0.13 | $0.56 | ||
| Q4 24 | $-0.09 | $0.43 | ||
| Q3 24 | $-3.35 | $0.38 | ||
| Q2 24 | $-0.11 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | $23.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.2B | $220.0M |
| Total Assets | $8.7B | $668.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.8B | $23.2M | ||
| Q3 25 | $1.7B | $17.1M | ||
| Q2 25 | $1.7B | $13.2M | ||
| Q1 25 | $1.5B | $21.2M | ||
| Q4 24 | $1.4B | $6.3M | ||
| Q3 24 | $1.3B | $8.9M | ||
| Q2 24 | $1.2B | $13.9M |
| Q1 26 | $8.2B | — | ||
| Q4 25 | $11.9B | $220.0M | ||
| Q3 25 | $11.9B | $212.4M | ||
| Q2 25 | $12.1B | $202.5M | ||
| Q1 25 | $12.0B | $193.0M | ||
| Q4 24 | $12.1B | $181.9M | ||
| Q3 24 | $12.1B | $174.3M | ||
| Q2 24 | $14.7B | $167.8M |
| Q1 26 | $8.7B | — | ||
| Q4 25 | $12.5B | $668.6M | ||
| Q3 25 | $12.5B | $670.5M | ||
| Q2 25 | $12.6B | $659.0M | ||
| Q1 25 | $12.5B | $664.6M | ||
| Q4 24 | $12.6B | $648.9M | ||
| Q3 24 | $12.6B | $655.5M | ||
| Q2 24 | $15.3B | $654.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.0M | $21.1M |
| Free Cash FlowOCF − Capex | — | $11.6M |
| FCF MarginFCF / Revenue | — | 3.4% |
| Capex IntensityCapex / Revenue | — | 2.9% |
| Cash ConversionOCF / Net Profit | — | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | $42.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $75.0M | — | ||
| Q4 25 | $113.0M | $21.1M | ||
| Q3 25 | $167.0M | $15.6M | ||
| Q2 25 | $213.0M | $2.9M | ||
| Q1 25 | $109.0M | $34.1M | ||
| Q4 24 | $204.0M | $2.7M | ||
| Q3 24 | $126.0M | $24.5M | ||
| Q2 24 | $30.0M | $12.4M |
| Q1 26 | — | — | ||
| Q4 25 | $86.0M | $11.6M | ||
| Q3 25 | $143.0M | $7.5M | ||
| Q2 25 | $199.0M | $-4.2M | ||
| Q1 25 | $95.0M | $27.6M | ||
| Q4 24 | $191.0M | $-6.9M | ||
| Q3 24 | $104.0M | $18.0M | ||
| Q2 24 | $6.0M | $3.6M |
| Q1 26 | — | — | ||
| Q4 25 | 19.3% | 3.4% | ||
| Q3 25 | 28.4% | 2.2% | ||
| Q2 25 | 39.3% | -1.3% | ||
| Q1 25 | 21.7% | 8.2% | ||
| Q4 24 | 39.0% | -2.1% | ||
| Q3 24 | 21.4% | 5.6% | ||
| Q2 24 | 1.4% | 1.2% |
| Q1 26 | — | — | ||
| Q4 25 | 6.1% | 2.9% | ||
| Q3 25 | 4.8% | 2.4% | ||
| Q2 25 | 2.8% | 2.2% | ||
| Q1 25 | 3.2% | 1.9% | ||
| Q4 24 | 2.7% | 2.9% | ||
| Q3 24 | 4.5% | 2.0% | ||
| Q2 24 | 5.5% | 2.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | 1.32× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 2.60× | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | 2.72× | ||
| Q2 24 | — | 1.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MBLY
Segment breakdown not available.
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
